Skip to main content

News of Note—Pfizer, Sanofi Pasteur and more

In this week's News of Note, GeoVax teamed with Emory University on a therapeutic HPV vaccine. (Pixabay)

> Pfizer's vaccine sales grew 10% in the second quarter to $1.4 billion. Release

> Sanofi's vaccines sales slipped during the second quarter due to a supply issue in China; timing of government orders for its polio, pertussis and Hib franchise; and a tough year-over-year comparison for Menactra. Release

> GeoVax teamed with Emory University to develop a therapeutic HPV vaccine. Release

> Sanofi cut a phase 2 tuberculosis vaccine from its pipeline. Endpoints News story

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.